Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 26 out of 100. Risk genes beyond APOE

Topic: Amyloid, tau and blood-test diagnosis

Esse artigo buscou abordar a Doença de Alzheimer de Início Precoce (DAIP) acerca do curso clínico, dos fatores predisponentes e do manejo, por meio de uma revisão de literatura, com ênfase na diferenciação entre DAIP e Doença de Alzheimer de Início Tardio (DAIT), incluindo artigos publicados entre 2015 e 2025, obtidos nas bases de dados “Alzheimer's Association”, “ScienceDirect”, “Cochrane” e “PubMed”, utilizando as palavras-chave “Alzheimer”, “early” e “on-set”, com o conectivo AND. A pesquisa evidenciou que a DAIP possui curso clínico mais agressivo, com manifestações não amnésicas, devido ao maior acúmulo de proteína tau e deposição de beta-amiloide, favorecendo um declínio cognitivo acelerado, e dentre os fatores predisponentes estão o estresse crônico e a genética, com mutações nos genes PSEN1, PSEN2 e APP. O diagnóstico envolve avaliação clínica, uso de biomarcadores e exames de imagem e seu manejo inclui controle sintomatológico e terapias emergentes como imunoterapia passiva e terapia gênica. O estudo aponta que a influência genética é o principal fator de impacto na formação expressiva de placas beta-amiloides e seu curso clínico difere por iniciar com um quadro de perda neurofuncional não amnésica, sendo tais características fundamentais para o direcionamento do diagnóstico e manejo precoces.

Key findings

Why it matters

This literature review describes that early-onset Alzheimer's disease has a more aggressive clinical course with non-amnestic manifestations, and that genetic mutations in PSEN1, PSEN2 and APP are among the predisposing factors. It discusses diagnosis and management including symptomatic control and emerging therapies, but presents no new treatment or cure.

Study details

How this study scored 26/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 0 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 26 of 100.26 of 100 points earned74 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Revista Ibero-Americana de Humanidades, Ciências e Educação)
Journal's citation record 0 / 4 Revista Ibero-Americana de Humanidades, Ciências e Educação: journal h-index 19 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author Fernanda Luiza Andrade de Azevedo: h-index 3 (OpenAlex, whole career)
Institution's track record 0 / 3 Universidade Estadual de Santa Cruz: institution h-index 144 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 26 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

de Araújo, D. B., Zapula, A. C. D., Rodrigues, D. C., Gil, A. d. J. R., & de Azevedo, F. L. A. (2026). ALZHEIMER PRECOCE: FATORES PREDISPONENTES, DIAGNÓSTICO E MANEJO. Revista Ibero-Americana de Humanidades, Ciências e Educação. https://doi.org/10.51891/rease.v12i5.26250

Vancouver

de Araújo DB, Zapula ACD, Rodrigues DC, Gil AdJR, de Azevedo FLA. ALZHEIMER PRECOCE: FATORES PREDISPONENTES, DIAGNÓSTICO E MANEJO. Revista Ibero-Americana de Humanidades, Ciências e Educação. 2026. doi:10.51891/rease.v12i5.26250.

BibTeX

@article{dearaujo2026-3395e97f,
  author  = {de Araújo, Dillhyenne Badaró and Zapula, Ana Clara Dias and Rodrigues, Dayla Cavalcante and Gil, Amanda de Jesus Rodrigues and de Azevedo, Fernanda Luiza Andrade},
  title   = {{ALZHEIMER PRECOCE: FATORES PREDISPONENTES, DIAGNÓSTICO E MANEJO}},
  journal = {Revista Ibero-Americana de Humanidades, Ciências e Educação},
  year    = {2026},
  doi     = {10.51891/rease.v12i5.26250},
  url     = {https://doi.org/10.51891/rease.v12i5.26250}
}

Related studies in Risk genes beyond APOE

Similar studies

More on Risk genes beyond APOE

See all studies in Risk genes beyond APOE →